Hellauer, Magdalena and Hudson, Stephen and Johnson, Julienne (2012) A pharmaceutical care plan for the management of chronic obstructive pulmonary disease (COPD). International Journal of Clinical Pharmacy, 34 (1). p. 206.Full text not available in this repository. (Request a copy from the Strathclyde author)
Abstract of a paper from ESCP 40th International Symposium on Clinical Pharmacy. Clinical Pharmacy: Connecting Care and Outcomes Dublin Ireland, 19–21 October 2011. COPD is one of the world’s leading causes of death. Smoking of tobacco being the major risk factor, the incidence of the disease is expected to increase by 33% in the next 20 years A Pharmaceutical Care Plan (PCP) is a systematic documentation of patients’ pharmaceutical care issues, the desired outcomes and the required actions that need to be undertaken to fulﬁl these outcomes.
|Keywords:||COPD , chronic obstructive pumonary disease , smoking, Therapeutics. Pharmacology, Pharmacology (medical), Pharmacology, Pharmacy, Pharmaceutical Science, Toxicology|
|Subjects:||Medicine > Therapeutics. Pharmacology|
|Department:||Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences|
|Depositing user:||Pure Administrator|
|Date Deposited:||22 Feb 2012 16:53|
|Last modified:||17 Feb 2017 01:06|